Homozygous deletions (HD) provide an important resource for identifying the location of candidate tumor suppressor genes. To identify the tumor suppressor gene in oral cancer, we employed high-resolution comparative genomic hybridization (CGH)-array analysis. We identified a homozygous loss of FAT (4q35), a new member of the human cadherin superfamily, from genome-wide screening of copy number alterations in one primary oral cancer. This result was evaluated by genomic polymerase chain reaction in 13 oral cancer cell lines and 20 primary oral cancers and Southern blot in the cell lines. We found frequent exonic HD of FAT in the cell lines (3/13, 23%) and in primary oral cancers (16/20, 80%). FAT expression was absent in these cell lines. Homozygous deletion hot spots were observed in exon 1 (9/20, 45%) and exon 4 (7/20, 35%). Moreover, loss of gene expression was identified in other types of squamous cell carcinoma. The methylation status of the FAT CpG island in squamous cell carcinomas correlated negatively with its expression. Our results identify mutations in FAT as an important factor in the development of oral cancer and indicate the importance of FATs function in some squamous cell carcinomas.
DNA-PK is a nuclear protein with serine/threonine kinase activity and forms a complex consisting of the DNA-PKcs and a heterodimer of Ku70 and Ku80 proteins. Recent laboratory experiments have demonstrated that the DNA-PK complex formation is one of the major pathways by which mammalian cells respond to DNA double-strand breaks induced by ionizing radiation. In this study, we evaluated the relationship between expression levels of DNA-PKcs, Ku70 and Ku80 proteins and radiation sensitivity in oral squamous cell carcinoma (OSCC) cell lines and in OSCC patients treated with preoperative radiation therapy. The OSCC cell lines greatly differed in their response to irradiation, as assessed by a standard colony formation assay. However, the expression levels of the DNA-PK complex proteins were all similar, and there was no association between the magnitude of their expression and the tumor radiation sensitivity. Expression of DNA-PK complex proteins increased after radiation treatment, and the in- he DNA-PK complex is one of the major pathways by which cells respond to DNA double-strand breaks (DSBs). The DNA-PK complex consists of a heterodimer comprising 70-and 80-kDa proteins termed Ku and a 465-kDa serine/ threonine protein kinase catalytic subunit termed DNA-PKcs.
1)The Ku (p70/p80) component functions as an activator of the catalytic subunit, and also represents the major double-stranded DNA binding protein.1, 2) DNA-PK plays an important role in the repair of DSBs and in V(D)J recombination.3) Tumor cell lines defective in the expression of either Ku or DNA-PKcs exhibit marked radiation sensitivity. Cells lacking DNA-PK activity because of defects in DNA-PK components, such as human malignant glioma M059J cells and cells derived from scid mice, show hypersensitivity to ionizing radiation.3-7) These previous laboratory findings suggested that DNA-PK is a candidate as a predictor of cellular radiation sensitivity. There is, however, little information on the expression of DNA-PK in primary human tumors and the correlation, if any, with radiation sensitivity, though the results are not definitive. [8][9][10][11] Therefore, the aim of this study is to evaluate the relationship between expression levels of DNA-PK complex proteins and radiation sensitivity.
Materials and MethodsCell culture. All SCC cell lines were grown in Ham/F12: DMEM (1:1) supplemented with 10% fetal bovine serum, 24 µg/ml adenine, 0.4 µg/ml hydrocortisone and 50 units/ml penicillin and streptomycin. The HSC2, HSC3 and HSC 4 cell lines were provided by Japanese Collection Research Bioresources. The SCC15, SCC25, SCC66 and SCC111 cell lines were provided by Dr.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.